$25.52
0.230.89%
마지막 업데이트: Oct 2, 10:25 AM
$25.69
0.401.58%
Benzinga
Benzinga
Benzinga
금요일, 10월 02
Benzinga
© 2026 Benzinga | All Rights Reserved
Arcutis Biotherapeutics (ARQT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.05 | $-0.05 | $0.07 | $-0.10 |
| Actual | $0.11 | $-0.09 | $0.13 | $0.06 |
| Surprise | +120.0% | -80.0% | +85.7% | +160.0% |
| Revenue | ||||
| Estimate | $117.7M | $102.8M | $114.1M | $86.7M |
| Actual | $129.9M | $105.4M | $129.5M | $99.2M |
| Surprise | +10.3% | +2.57% | +13.5% | +14.4% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.17 | $0.23 | $0.08 | $0.19 |
| Revenue | ||||
| Consensus | $141.7M | $160.2M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0.11 | $0.05 | 120.0 % |
| Q1 | May 6, 2026 | $-0.09 | $-0.05 | -80.0 % |
| Q4 | Feb 25, 2026 | $0.13 | $0.07 | 85.7 % |
| Q3 | Oct 28, 2025 | $0.06 | $-0.10 | 160.0 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $129.86M | $117.72M | 10.3 % |
| Q1 | May 6, 2026 | $105.40M | $102.76M | 2.57 % |
| Q4 | Feb 25, 2026 | $129.50M | $114.10M | 13.5 % |
| Q3 | Oct 28, 2025 | $99.22M | $86.74M | 14.4 % |